We conducted a pragmatic , open-label , noninferiority trial in New Zealand in which @ adult daily smokers who were motivated to quit and called the national quitline were randomly assigned in a @:@ ratio to receive cytisine for @ days or nicotine-replacement therapy for @ weeks .